Fear of Cancer Recurrence in Patients with Sarcoma in the United Kingdom

Anika Petrella, Lesley Storey, Nicholas J. Hulbert-Williams, Lorna A. Fern, Maria Lawal, Craig Gerrand, Rachael Windsor, Julie Woodford, Jennie Bradley, Hatty O’Sullivan, Mary Wells, Rachel M. Taylor

Research output: Contribution to journalArticle (journal)peer-review

4 Citations (Scopus)
41 Downloads (Pure)


Fear of cancer recurrence (FCR) is a persistent concern among those living with cancer and is associated with a variety of negative psychosocial outcomes. However, people with sarcoma have been underrepresented within this area of research. We aimed to determine the prevalence of FCR experienced by people with sarcoma in the United Kingdom and explore factors that may predict FCR, such as the perceived impact of cancer and psychological flexibility. Participants (n = 229) with soft tissue (n = 167), bone (n = 25), and gastrointestinal stromal tumours (n = 33) completed an online survey including the self-reported measures of FCR, the perceived physical and psychological impact of cancer and psychological flexibility, and demographic information. Data were analysed using ANOVA and multiple regression modelling. Mean FCR scores (M = 91.4; SD = 26.5) were higher than those reported in meta-analytic data inclusive of all cancer types (M = 65.2; SD = 28.2). Interest in receiving support for FCR was also high (70%). Significant factors associated with FCR included cognitive and emotional distress and psychological flexibility, but not perceptions of the physical impact of cancer (R2 = 0.56). The negative association between psychological flexibility and FCR suggests the potential benefit of intervention approaches which foster psychological flexibility, such as acceptance and commitment therapy.
Original languageEnglish
Pages (from-to)956
Number of pages1
Issue number3
Early online date2 Feb 2023
Publication statusPublished - 1 Mar 2023


  • Cancer Research
  • Oncology


Dive into the research topics of 'Fear of Cancer Recurrence in Patients with Sarcoma in the United Kingdom'. Together they form a unique fingerprint.

Cite this